Exhibit 10.3
VIA E-MAIL
February 18, 2022
Jatin Shah, M.D.
4402 Dorothy Street
Bellaire, Texas 77401
Dear Jatin:
As we discussed, your employment with Karyopharm Therapeutics Inc. (the “Company”) will end effective at the close of business on February 18, 2022 (the “Separation Date”). As we also discussed, you will be eligible to receive the severance benefits described in paragraph 1 below if you sign and return this letter agreement to me by March 14, 2022 (but no earlier than February 18, 2022) and do not revoke your agreement (as described below). By signing and returning this letter agreement and not revoking your acceptance, you will be entering into a binding agreement with the Company and will be agreeing to the terms and conditions set forth in the numbered paragraphs below, including the release of claims set forth in paragraph 2. Therefore, you are advised to consult with an attorney before signing this letter agreement and you have been given at least twenty-one (21) days to do so. If you sign this letter agreement, you may change your mind and revoke your agreement during the seven (7) day period after you have signed it (the “Revocation Period”) by notifying me in writing. If you do not so revoke this letter agreement will become a binding agreement between you and the Company upon the expiration of the Revocation Period.
Although your receipt of the severance benefits is expressly conditioned on your entering into this letter agreement, the following will apply regardless of whether or not you timely sign and return this letter agreement:
If you elect to timely sign and return this letter agreement and do not revoke your acceptance within the Revocation Period, the following terms and conditions will also apply:
You will not be eligible for, nor shall you have a right to receive, any payments or benefits from the Company following the Separation Date other than as set forth in this paragraph.
If you have any questions about the matters covered in this letter agreement, please call me at (857) 297-2328 x253 or by email at steven.rotman@karyopharm.com.
Very truly yours,
By: /s/ Steven Rotman_______________________
Steven Rotman
Chief People & Corporate Engagement Officer
I hereby agree to the terms and conditions set forth above. I have been given at least twenty-one (21) days to consider this letter agreement, and I have chosen to execute this on the date below. I intend that this letter agreement will become a binding agreement between me and the Company if I do not revoke my acceptance in seven (7) days.
/s/ Jatin Shah________________________ Jatin Shah, M.D. | March 2, 2022______________________ Date |
To be returned in a timely manner as set forth on the first page of this letter agreement.